ESTUTC-5 New YorkLog in Sign up

IMRX
Immuneering Corporation Class A Common Stock
stockNASDAQ

At CloseNov 13, 2026 3:59:59 PM EST

3.71USD+1.090%(+0.04)847,339

Pre-marketNov 13, 2026 9:28:30 AM EST

3.73USD+1.635%(+0.06)

After-hoursNov 13, 2026 4:00:30 PM EST

3.71USD0.000%(-0.00)

3.1600Bid4.2100Ask1.0500Spread

Loading…

Loading…

240.60M

Healthcare

Biotechnology

HQ

Cambridge, MA, USA

68

Previous Close

$3.66

Beta

1.24

52-Week High

$8.48 2026-01-07

52-Week Low

$3.35 2026-11-05

SMA 50

$4.02

SMA 200

$4.75

Avg. Vol 10D

754,765

Avg. Vol 30D

774,851

Avg. Vol 90D

722,129

Relative Vol

0.96

64.76M

49.28M

76.09%

14,595,733

Short Interest %

29.66%

19.20

On/Off Exchange

52%/48%

56.90%

Short Vol % (off-exch)

37.08%

2.7700%

950,000

248,059

27,917

248,059

Net Income (TTM)

-66.5M

Diluted EPS (TTM)

-1.03

Free Cash Flow (TTM)

-61.8M

Return on Equity %

-33.53

Nov 12, 2026

04:58 PM ESTImmuneering Corporation (IMRX) Discusses Expanded Atebimetinib Development: Pancreatic and Anaplastic Thyroid Cancer Trials Transcript ·

Seeking Alpha

08:40 AM ESTAstellas, Immuneering Enter Pancreatic Cancer Trial Collaboration ·

RTTNews

07:30 AM ESTImmuneering Announces New Potentially Registrational Phase 2 Trial Evaluating Atebimetinib with Chemotherapy in Anaplastic Thyroid Cancer ·

GlobeNewswire Inc.

Nov 9, 2026

01:03 PM ESTImmuneering at guggenheim healthcare conference: pancreatic data in focus ·

Investing.com

07:30 AM ESTImmuneering Appoints Accomplished Commercial Leader Grant Bogle to Board of Directors ·

GlobeNewswire Inc.

IMRX Performance

Period	Price	Date	Change	Beta
1W	3.68	2026-11-06	+0.95%	-0.895
1M	3.56	2026-10-13	+4.35%	1.948
3M	5.20	2026-08-13	-28.56%	1.654
6M	5.38	2026-05-13	-30.95%	1.223
1Y	6.45	2025-11-13	-42.40%	1.241
2Y	1.71	2024-11-13	+117.25%	—
5Y	27.87	2021-11-12	-86.67%	1.183

IMRX Stock Summary

Immuneering Corporation Class A Common Stock (NASDAQ:IMRX) stock price today is $3.72, and today's volume is 747,433. IMRX is up 1.226% today. The 30 day average volume is 774,851. IMRX market cap is $240.60M with 64.76M shares outstanding.